|
[1]
|
姚开虎, 杨永弘. 原发性免疫缺陷病患儿的疫苗接种[J]. 中华实用儿科临床杂志, 2015, 30(9): 647-650.
|
|
[2]
|
Tangye, S.G., Al-Herz, W., Bousfiha, A., et al. (2022) Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, 42, 1473-1507. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
孙金峤. 特殊健康状态儿童预防接种专家共识之三——原发性免疫缺陷病的预防接种[J]. 中国实用儿科杂志, 2018, 33(10): 740-742.
|
|
[4]
|
蔡晓岚, 尹晓波, 吴秀清. 我国儿童预防接种的现状[J]. 沈阳医学院学报, 2020, 22(4): 352-355.
|
|
[5]
|
Jesus, N.S.C.D. and Rosenzweig, S.D. (2018) Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017. Frontiers in Immunology, 9, Article No. 1423. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
王琳, 郝利新, 白云骅. 医防融合, 促进特殊健康状态儿童免疫接种[J]. 中华预防医学杂志, 2022, 56(6): 673-678.
|
|
[7]
|
韩英, 胡丹丹, 韦茹, 等. 广东省特需人群接种门诊特殊健康状态儿童预防接种探索[J]. 中国疫苗和免疫, 2021, 27(6): 678-683.
|
|
[8]
|
宋红梅. 免疫功能异常患儿的预防接种专家共识(试行稿): “原发性免疫缺陷病”解读[J]. 中华儿科杂志, 2015, 53(12): 903-906.
|
|
[9]
|
古吉燕, 王念蓉, 张龙娇, 等. 重庆市特殊健康状态儿童计划免疫影响因素研究[J]. 现代医药卫生, 2021, 37(12): 1989-1993.
|
|
[10]
|
骆晓艳, 高志刚, 李永成, 等. 天津市6-71月龄儿童肠道病毒71型灭活疫苗疑似预防接种异常反应主动监测[J]. 中国疫苗和免疫, 2020, 26(3): 326-328.
|
|
[11]
|
Azarpanah, H., Farhadloo, M., Vahidov, R., et al. (2021) Vaccine Hesitancy: Evidence from an Adverse Events Following Immunization Database, and the Role of Cog-nitive Biases. BMC Public Health, 21, Article No. 1686. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Dudley, M.Z., Halsey, N.A., Omer, S.B., et al. (2020) The State of Vaccine Safety Science: Systematic Reviews of the Evidence. The Lancet Infectious Diseases, 20, E80-E89. [Google Scholar] [CrossRef]
|
|
[13]
|
Des Roches, A., Graham, F., Begin, P., et al. (2021) Evalu-ation of Adverse Reactions to Vaccines. The Journal of Allergy and Clinical Immunology: In Practice, 9, 3584-3597. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yadav, R.M., Dalvi, A., Gupta, M., et al. (2021) Spectrum of In-born Errors of Immunity in a Cohort of 90 Patients Presenting with Complications to BCG Vaccination in India. Scan-dinavian Journal of Immunology, 93, E13010. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Shaghaghi, M., Parvaneh, N., Ostad-Rahimi, P., et al. (2014) Combined Immunodeficiency Presenting with Vaccine- Associated Paralytic Poliomyelitis: A Case Report and Narrative Review of Literature. Immunological Investigations, 43, 292-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yao, N., Liu, Y., Xu, J.W., et al. (2022) Detection of a Highly Divergent Type 3 Vaccine-Derived Poliovirus in a Child with a Severe Primary Immunodeficiency Disorder—Chongqing, China, 2022. Morbidity and Mortality Weekly Report, 71, 1148-1150. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Shulman, L.M., Weil, M., Somech, R., et al. (2021) Underperformed and Underreported Testing for Persistent Oropharyngeal Poliovirus Infections in Primary Immune Deficient Patients—Risk for Reemergence of Polioviruses. Journal of the Pediatric Infectious Diseases Society, 10, 326-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Rubin, L.G., Levin, M.J., Ljungman, P., et al. (2014) 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. Clinical Infectious Diseases, 58, E44-E100. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
广东省医师协会儿科医师分会. 特殊状态儿童预防接种(广东)专家共识[J]. 中华实用儿科临床杂志, 2020, 35(6): 401-410.
|
|
[20]
|
Chen, H., Huang, Z., Chang, S., et al. (2022) Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered with Quadrivalent Split-Virion Inactivated Influenza Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine in China: A Multicentre, Non-Inferiority, Open-Label, Randomised, Controlled, Phase 4 Trial. Vaccine, 40, 5322-5332. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Robbins, A., Bahuaud, M., Hentzien, M., et al. (2021) The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients with Primary Humoral Immunodeficiency. Frontiers in Immunology, 12, Article ID: 697128. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Hansen, A.T., Söderström, A., Jørgensen, C.S., et al. (2021) Diagnostic Vaccination in Clinical Practice. Frontiers in Immunology, 12, Article ID: 717873. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Bonilla, F.A., 周钦华. 进展: 预防接种与原发性免疫缺陷病[J]. 中华临床免疫和变态反应杂志, 2018, 12(2): 247-254.
|
|
[24]
|
Bonilla, F.A. (2020) Vaccines in Patients with Pri-mary Immune Deficiency. Immunology and Allergy Clinics of North America, 40, 421-435. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
鲁晓伍. 治疗性疫苗的研究进展[J]. 中国生物制品学杂志, 2011, 24(4): 486-490.
|
|
[26]
|
Sobhani, N., Scaggiante, B., Morris, R., et al. (2022) Therapeutic Cancer Vaccines: From Biological Mechanisms and Engineering to Ongoing Clinical Trials. Cancer Treatment Reviews, 109, Article ID: 102429. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Shapiro, G.K. (2022) HPV Vaccination: An Underused Strategy for the Prevention of Cancer. Current Oncology, 29, 3780-3792. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Gernert, M., Kiesel, M., Fröhlich, M., et al. (2021) High Preva-lence of Genital Human Papillomavirus Infection in Patients with Primary Immunodeficiencies. Frontiers in Immunology, 12, Article ID: 789345. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Smith, S., Baxendale, H. and Sterling, J. (2017) Clearance of Recalcitrant Warts in a Patient with Idiopathic Immune Deficiency Following Administration of the Quadrivalent Human Papillomavirus Vaccine. Clinical and Experimental Dermatology, 42, 306-308. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Mao, H.H. and Chao, S. (2020) Advances in Vaccines. Advances in Bio-chemical Engineering/Biotechnology, 171, 155-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
孙碧君, 孙金峤. 新生儿原发性免疫缺陷病筛查进展[J]. 中国小儿急救医学, 2021, 28(8): 654-658.
|